Search research articles
Contact Us
Filters
Showing results (111-120 of 128) with videos related to
Page
of 13
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
July 16, 2021
Pre-vaccination and early B cell signatures predict antibody response to SARS-CoV-2 mRNA vaccine
Lela Kardava, Nicholas Rachmaninoff, William W Lau, et al.
Blood
|
April 12, 2012
Comprehensive analysis of unique cases with extraordinary control over HIV replication
Daniel Mendoza, Sarah A Johnson, Bennett A Peterson, et al.
The Journal of Experimental Medicine
|
November 13, 2008
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
R Brad Jones, Lishomwa C Ndhlovu, Jason D Barbour, et al.
Cell
|
March 13, 2021
Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19
Can Liu, Andrew J Martins, William W Lau, et al.
Nature Communications
|
January 21, 2025
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies
Jesper D Gunst, Jesal Gohil, Johanthan Z Li, et al.
Annals of Internal Medicine
|
May 23, 2022
A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings
Michael C Sneller, C Jason Liang, Adriana R Marques, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2026
Dynamic Antigen Expression and Intrinsic CTL Resistance in HIV Reservoir Clones
Isabella A T M Ferreira, Alberto Herrera, Tan Thinh Huynh, et al.
Nature Communications
|
August 19, 2022
SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8<sup>+</sup> T-cells
Eva M Stevenson, Sandra Terry, Dennis Copertino, et al.
Nature Reviews. Immunology
|
July 21, 2012
Towards an HIV cure: a global scientific strategy
, Steven G Deeks, Brigitte Autran, et al.
The Journal of Infectious Diseases
|
August 8, 2018
The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies
Golnaz Namazi, Jesse M Fajnzylber, Evgenia Aga, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 128) with videos related to
Sort By:
Page
of 13
Medrxiv : the Preprint Server for Health Sciences
|
July 16, 2021
Pre-vaccination and early B cell signatures predict antibody response to SARS-CoV-2 mRNA vaccine
Lela Kardava, Nicholas Rachmaninoff, William W Lau, et al.
Blood
|
April 12, 2012
Comprehensive analysis of unique cases with extraordinary control over HIV replication
Daniel Mendoza, Sarah A Johnson, Bennett A Peterson, et al.
The Journal of Experimental Medicine
|
November 13, 2008
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
R Brad Jones, Lishomwa C Ndhlovu, Jason D Barbour, et al.
Cell
|
March 13, 2021
Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19
Can Liu, Andrew J Martins, William W Lau, et al.
Nature Communications
|
January 21, 2025
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies
Jesper D Gunst, Jesal Gohil, Johanthan Z Li, et al.
Annals of Internal Medicine
|
May 23, 2022
A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings
Michael C Sneller, C Jason Liang, Adriana R Marques, et al.
Biorxiv : the Preprint Server for Biology
|
March 11, 2026
Dynamic Antigen Expression and Intrinsic CTL Resistance in HIV Reservoir Clones
Isabella A T M Ferreira, Alberto Herrera, Tan Thinh Huynh, et al.
Nature Communications
|
August 19, 2022
SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8<sup>+</sup> T-cells
Eva M Stevenson, Sandra Terry, Dennis Copertino, et al.
Nature Reviews. Immunology
|
July 21, 2012
Towards an HIV cure: a global scientific strategy
, Steven G Deeks, Brigitte Autran, et al.
The Journal of Infectious Diseases
|
August 8, 2018
The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies
Golnaz Namazi, Jesse M Fajnzylber, Evgenia Aga, et al.
Page
of 13